Company / Depreciation & Amortization
Medtronic Depreciation & Amortization History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$2.6B
FY2026
5-year range
$2.6B / $2.9B
FY2022-FY2026
Trend
-1.9%
vs FY2025
Sector context
#5 of 142
Health Care
What the data says
Among 142 Health Care companies, Medtronic is in the bottom 4% for depreciation & amortization. Depreciation & Amortization remained relatively stable over the past 10 years, with values between $2.6B and $2.9B.
Based on SEC 10-K filings.
$2.6B in FY2026 with a 5-year CAGR of -0.1%. Top quartile in the Health Care sector.
Improved from $2.9B to $2.6B over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -0.7%
- 5-Year CAGR
- -0.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 142This company $2.6B Sector average $347.4M
▼
+661.9% above sector average
Key checks
Key Insights
- 5-year CAGR of -0.1%, indicating a declining trend.
- In FY2026, depreciation & amortization decreased 1.9% year-over-year.
- Ranks #5 out of 142 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2024.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $2.6B | -1.9% |
| FY2025 | $2.7B | -5.7% |
| FY2024 | $2.9B | +5.9% |
| FY2023 | $2.7B | +1.5% |
| FY2022 | $2.7B | +0.2% |
| FY2021 | $2.7B | -1.6% |
| FY2020 | $2.7B | +1.5% |
| FY2019 | $2.7B | +0.2% |
| FY2018 | $2.7B | +0.6% |
| FY2017 | $2.6B | -9.4% |
As of FY2026 · SEC 10-K · Updated Jun 30, 2026